EP Patent

EP3972599B1 — Combination for lowering serum phosphate in a patient

Assigned to Ardelyx Inc · Expires 2025-10-22 · 1y expired

What this patent protects

Patent listed against Accrufer.

Drugs covered by this patent

Accrufer (FERRIC MALTOL) · Shield Tx

Patent Metadata

Patent number: EP3972599B1
Jurisdiction: EP
Classification: —
Expires: 2025-10-22
Drug substance claim: No
Drug product claim: No
Assignee: Ardelyx Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.